Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius
Journal of Medical Microbiology · 2025
DOI: 10.1099/jmm.0.002109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Peter Fowler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Comparative Medicine and Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Enterococcaceae. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: College of Agriculture and Natural Resources, Michigan State University, North Central SARE.
Abstract (Originalsprache)
Introduction
Melissococcus plutonius is the causative agent of European foulbrood (EFB), a disease of honey bees that is endemic in many areas of the USA. Only one antibiotic, oxytetracycline (OTC), is approved for EFB management, and there have been reports of recalcitrance. Gap Statement. Resistant strains of M. plutonius have been identified in Canada and Japan, but methodology differs between studies, making reliable comparisons difficult. Additionally, no M. plutonius isolates from the USA have yet been tested for susceptibility to OTC, despite decades of use.
Aim
Here, we determine the impact of media, time and persistence on the results of commonly used growth and antibiotic resistance assays using regionally representative M. plutonius isolates. Methodology. Twelve genetically diverse isolates of M. plutonius were tested for susceptibility to OTC using previously published assays, but with variations in media and time to determine factors that may be impacting results.
Results
Media composition and incubation time dramatically impact antibiotic susceptibility assays for M. plutonius , differing widely between strains, likely due to differences in OTC stability. Assays that ended when growth appeared on antibiotic-free agar showed that all strains remained susceptible to OTC with an MIC of 2–4 µg ml −1 . However, M. plutonius remains viable after OTC efficacy wanes, with some strains able to persist at room temperature for at least 3.5 years.
Conclusion
To standardize antibiotic susceptibility testing for M. plutonius, we recommend the use of M110 media due to stability and speed of growth. However, all strains of M. plutonius persist on M110 beyond the window of OTC efficacy, complicating assay results and interpretation, and additional research is needed to determine the clinical implications of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Comparative Medicine and Integrative Biology, College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
- College of Veterinary Medicine, Michigan State University, East Lansing, MI, USA.
- Department of Entomology, Michigan State University, East Lansing, MI, USA.
Förderung
- College of Agriculture and Natural Resources, Michigan State University
- North Central SARE
Zitieren
APA
Fowler, P., Hawley, R., & Milbrath, M. O. (2025). Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002109
Vancouver
Fowler P, Hawley R, Milbrath MO. Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002109
BibTeX
@article{Fowler2025,
author = {Fowler, Peter and Hawley, Robyn and Milbrath, Meghan O},
title = {Potential confounding factors in currently used antibiotic susceptibility assays for the honey bee pathogen Melissococcus plutonius},
journal = {Journal of Medical Microbiology},
year = {2025},
doi = {10.1099/jmm.0.002109}
}
EUVIMED